niket


SUBMITTED BY: niket

DATE: Oct. 7, 2022, 12:15 p.m.

FORMAT: Text only

SIZE: 2.9 kB

HITS: 485

  1. Warts Therapeutics Market Segmentation and Forecast Analysis up to 2028
  2. The “Warts Therapeutics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Treatment, and End User,” the market is projected to reach US$ 2,314.60 million by 2028 from US$ 1,829.54 million in 2021; it is expected to grow at a CAGR of 3.4% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
  3. The COVID-19 pandemic has negatively impacted the warts therapeutics market in Africa. In Africa, COVID-19 has threatened the control and progress of major high-burden diseases such as HIV, and other sexually transmitted diseases (STIs). With the continuous spread of COVID-19 in Africa, the limited testing, and decreased access to expert STI clinical further fueling an STI epidemic especially among marginalized populations.
  4. Based on treatment, the warts therapeutics market is segmented into physical destruction, immunomodulation, and chemical destruction. The market for physical destruction is further segmented into cryotherapy, surgical removal, and laser treatment. Moreover, the market for immunomodulation is subsegmented into interferons, retinoids, and zinc. The warts therapeutics market for chemical destruction is further segmented into bleomycin, cantharidin, salicylic acid, and others. The physical destruction segment is the largest shareholder in the market, and it is estimated to register the highest CAGR during the forecast period.
  5. Get FREE Sample Copy @
  6. The developments in the warts therapeutics market have been characterized as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as launches, expansion, enhancement as well as relocation. Inorganic growth strategies witnessed in the market were mergers & acquisitions, partnership, collaborations, alliance, and agreement & joint ventures. These activities have paved way for expansion of business and customer base of market players.
  7. Market leaders operating in the market have undertaken various organic growth strategies in the warts therapeutics market. The Warts Therapeutics market majorly consists of the players Bausch Health Companies Inc., Nielsen BioSciences, Inc., Euro Vital Pharma GmbH, Cipla Inc., Koninklijke Utermöhlen NV, Novan, Inc., Scholl's Wellness Company, TEVA PHARMACEUTICAL INDUSTRIES LTD, Verrica Pharmaceuticals Inc., GlaxoSmithKline plc., and AIM ImmunoTech Inc.
  8. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.

comments powered by Disqus